Over-expression of GAPDH in human colorectal carcinoma as a preferred target of 3-Bromopyruvate Propyl Ester
- 18 February 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Bioenergetics and Biomembranes
- Vol. 44 (1), 117-125
- https://doi.org/10.1007/s10863-012-9420-9
Abstract
It has long been observed that many cancer cells exhibit increased aerobic glycolysis and rely more on this pathway to generate ATP and metabolic intermediates for cell proliferation. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a key enzyme in glycolysis and has been known as a housekeeping molecule. In the present study, we found that GAPDH expression was significantly up-regulated in human colorectal carcinoma tissues compared to the adjacent normal tissues, and also increased in colon cancer cell lines compared to the non-tumor colon mucosa cells in culture. The expression of GAPDH was further elevated in the liver metastatic tissues compared to the original colon cancer tissue of the same patients, suggesting that high expression of GAPDH might play an important role in colon cancer development and metastasis. Importantly, we found that 3-bromopyruvate propyl ester (3-BrOP) preferentially inhibited GAPDH and exhibited potent activity in inducing colon cancer cell death by causing severe depletion of ATP. 3-BrOP at low concentrations (1–10 μM) inhibited GAPDH and a much higher concentration (300 μM) was required to inhibit hexokinase-2. The cytotoxic effect of 3-BrOP was associated with its inhibition of GAPDH, and colon cancer cells with loss of p53 were more sensitive to this compound. Our study suggests that GAPDH may be a potential target for colon cancer therapy.Keywords
This publication has 33 references indexed in Scilit:
- The combination of the novel glycolysis inhibitor 3-BrOP and rapamycin is effective against neuroblastomaInvestigational New Drugs, 2010
- Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvateBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2009
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Hexokinase-2 bound to mitochondria: Cancer's stygian link to the “Warburg effect” and a pivotal target for effective therapySeminars in Cancer Biology, 2009
- Transcriptome Profile of Human Colorectal AdenomasMolecular Cancer Research, 2007
- Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cellsLeukemia, 2005
- Increased expression of glycolysis‐associated genes in oncogene‐transformed and growth‐accelerated statesMolecular Carcinogenesis, 1989
- Reactivity of the thiol groups of Escherichia coli phosphofructo-1-kinaseBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1988
- Irreversible inhibition of carbonic anhydrase by the carbon dioxide analog cyanogenBiochemical and Biophysical Research Communications, 1985
- On the Origin of Cancer CellsScience, 1956